JULIE LEWIS: Open Payments
NPI 1316670235 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 19 payments from 11 companies in 2025. Trend: 2023 $352 · 2024 $773 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Amgen Inc. | 1 | $117 |
| Novo Nordisk Inc | 1 | $109 |
| CVRx, Inc. | 2 | $107 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: LEQVIO, REPATHA, Ozempic, Barostim Neo System, FARXIGA, VERQUVO, Assure WCD, AMVUTTRA.
Industry payments across FL — which companies pay providers there.
